- Common shares of Reunion Neuroscience (REUN) (formerly, Field Trip Health Ltd.) commence trading on the Toronto Stock Exchange (TSX) under the ticker symbol REUN on August 17th
- The TSX listing marks the last step in the reorganization that resulted in the spinout of the company’s former subsidiary, Field Trip Health & Wellness
- Reunion Neuroscience (REUN) is a global leader in the discovery and development of innovative psychedelic-inspired therapeutic solutions for improved mental health conditions by developing proprietary serotonin receptor agonist compounds
- Reunion Neuroscience (REUN) is up on the day, trading at C$1.05 at 1:57 pm ET
Common shares of Reunion Neuroscience (REUN) will begin trading on the TSX under the ticker symbol REUN on August 17.
Trading of the company’s shares on the TSX represents the last step in the corporate reorganization that resulted in the spinout of the company’s former subsidiary, Field Trip Health & Wellness (FTHW) into a stand-alone public company listed on the TSX Venture Exchange. Reunion continues to hold a 21.84 per cent interest in FTHW.
Reunion Neuroscience (REUN) is a global leader in the discovery and development of innovative psychedelic-inspired therapeutic solutions for improved mental health conditions by developing proprietary serotonin receptor agonist compounds.
Reunion Neuroscience (REUN) is up on the day, trading at C$1.05 at 1:57 pm ET.
